Company intelligence / Profile preview

Izotropic

Vancouver, British Columbia, Canadaizocorp.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Izotropic has achieved regulatory alignment with the FDA for its pivotal U.S. clinical trial of the IzoView dedicated breast CT system. The company has completed a strategic business plan and financial model to support commercialization efforts. Clinical studies are being prepared in partnership with ICON plc to support FDA submission; no final clinical results have been published yet.

Therapeutic areas: Oncology
Modalities: DeviceImaging platform
Industry: Medical Imaging

Partnerships

ICON plc – engaged as CRO for pivotal U.S. study preparation and execution

Beyond the preview

Go deeper on Izotropic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Izotropic.

Explore the full profile